CBMG's goal is to develop safe and effective cellular medicine therapies for indications that represent a large unmet medical need in China and the US.
Excellence in Cell Therapy Recognized by 2 Global Pharma
Systematic Approach and Highly Differentiated Pipeline
End-to-end R&D and CMC Capabilities
Lower valuation than peers given development progress, growth catalysts and addressable market size.
Top Notch Leadership Backed by MNCs and Renowned Investors
Assets with first-to-market & best-in-class potentials